ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi as shareholders, is pleased to announce it has successfully completed ...

The Navigating HIV video series aims to role model what open and honest conversations between patients and HCPs can look like.

Big drug maker Gilead expects to take a billion-dollar hit this year via drug-pricing provisions in the Inflation Reduction ...

The number of U.S. product recalls remained high during 2024 with more than 3,200 events recorded for the second consecutive year. According to Sedgwick brand protection's 2025 U.S. State of the ...

A patent dispute between ViiV Healthcare and Gilead Sciences ... down to lingering effects of the pandemic on healthcare consultations, but the company's cell therapy franchise – Yescarta ...

"They focus the company on leading businesses with innovation ... GSK's revenues will be in four key franchises: Respiratory, HIV (ViiV Healthcare), Vaccines and Consumer Healthcare.

However, what health care companies do with their profits—some made through government programs such as Medicare—remains murky. The research team focused on U.S. health care companies on the ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on P3 Health Partners (PIII – Research Report) and ...

The health sector had 21 companies reporting their quarterly earnings this week, with 18 of them beating profit estimates for the quarter. Quarter-To-Date, The Health Care Select Sector SPDR Fund ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Oric Pharmaceuticals (ORIC – Research Report) ...